Advanced Biomed Inc Proceeds from Interest Received
Advanced Biomed Inc (ADVB) reported Proceeds from Interest Received of $15.40 thousand for the 9-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromInterestReceived · last filed 2025-05-15
- Advanced Biomed Inc proceeds from interest received for the quarter ending 2025-03-31 was -$24.00, a 123.08% decline year-over-year.
- Advanced Biomed Inc proceeds from interest received for the quarter ending 2024-03-31 was $104.00.
| Period end | Proceeds from Interest Received 3 month | Proceeds from Interest Received 6 month | Proceeds from Interest Received 9 month |
|---|---|---|---|
| 2025-03-31 | -$24.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-15 | $15.40K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $15.43K 10-Q · filed 2025-04-15 | ||
| 2024-03-31 | $104.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-15 | $20.08K 10-Q · filed 2025-05-15 | |
| 2023-12-31 | $19.98K 10-Q · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |